NCT02649049

Brief Summary

Patients with NAFLD and matched controls will be asked about their demographic status, and their previous year dietary intakes using a validated FFQ.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

January 3, 2016

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 7, 2016

Completed
25 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2016

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2016

Completed
Last Updated

September 22, 2016

Status Verified

September 1, 2016

Enrollment Period

1.1 years

First QC Date

January 3, 2016

Last Update Submit

September 21, 2016

Conditions

Dietary IntakeNAFLD

Outcome Measures

Primary Outcomes (1)

  • nonalcoholic fatty liver disease diagnosed by Fibroscan

    patients with confirmed diagnosis will be asked about their dietary intakes

    6 months

Study Arms (2)

Patients with NAFLD

Patients with NAFLD are the cases.

Other: there is no intervention

control group

Healthy people without NAFLD are controls.

Other: there is no intervention

Interventions

there is no interventionOTHER
Patients with NAFLDcontrol group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

patients with NAFLD diagnosed using Fibroscan without any other chronic disorders.

You may qualify if:

  • age more than 18
  • NAFLD was diagnosed by Fibroscan and other hepatic disorders ruled out

You may not qualify if:

  • not completing more than 10% of the questionnaire

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NNFTRI clinic

Tehran, Tehran Province, 19435, Iran

Location

MeSH Terms

Conditions

Non-alcoholic Fatty Liver Disease

Condition Hierarchy (Ancestors)

Fatty LiverLiver DiseasesDigestive System Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Prof

Study Record Dates

First Submitted

January 3, 2016

First Posted

January 7, 2016

Study Start

January 1, 2015

Primary Completion

February 1, 2016

Study Completion

March 1, 2016

Last Updated

September 22, 2016

Record last verified: 2016-09

Locations

IR(1)